Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$47.98 - $54.4 $7,196 - $8,160
-150 Reduced 3.72%
3,884 $210,000
Q4 2023

Jan 31, 2024

SELL
$48.48 - $57.85 $10,083 - $12,032
-208 Reduced 4.9%
4,034 $206,000
Q3 2023

Oct 11, 2023

SELL
$57.89 - $64.73 $98,934 - $110,623
-1,709 Reduced 28.72%
4,242 $246,000
Q2 2023

Jul 18, 2023

SELL
$63.71 - $70.74 $527,901 - $586,151
-8,286 Reduced 58.2%
5,951 $380,000
Q1 2023

May 10, 2023

BUY
$65.71 - $74.53 $188,456 - $213,752
2,868 Added 25.23%
14,237 $986,000
Q4 2022

May 17, 2023

SELL
$68.48 - $81.09 $196,400 - $232,566
-2,868 Reduced 20.14%
11,369 $817,000
Q4 2022

Jan 17, 2023

BUY
$68.48 - $81.09 $182,293 - $215,861
2,662 Added 30.57%
11,369 $818,000
Q3 2022

Oct 18, 2022

BUY
$0.13 - $76.84 $40 - $23,897
311 Added 3.7%
8,707 $619,000
Q2 2022

Jul 14, 2022

BUY
$72.62 - $79.98 $24,472 - $26,953
337 Added 4.18%
8,396 $647,000
Q1 2022

Apr 21, 2022

BUY
$61.48 - $73.72 $11,373 - $13,638
185 Added 2.35%
8,059 $589,000
Q4 2021

Feb 10, 2022

BUY
$53.63 - $62.52 $148,072 - $172,617
2,761 Added 54.0%
7,874 $491,000
Q3 2021

Oct 20, 2021

BUY
$59.17 - $69.31 $93,192 - $109,163
1,575 Added 44.52%
5,113 $303,000
Q2 2021

Jul 26, 2021

BUY
$61.91 - $67.42 $14,115 - $15,371
228 Added 6.89%
3,538 $236,000
Q4 2020

Jan 20, 2021

BUY
$57.74 - $65.43 $191,119 - $216,573
3,310 New
3,310 $205,000
Q1 2020

May 06, 2020

SELL
$46.4 - $67.43 $152,424 - $221,507
-3,285 Closed
0 $0
Q4 2019

Jan 21, 2020

BUY
$49.21 - $64.19 $161,654 - $210,864
3,285 New
3,285 $211,000
Q1 2018

May 24, 2019

SELL
$59.92 - $68.98 $198,275 - $228,254
-3,309 Closed
0 $0
Q4 2017

May 23, 2019

BUY
$59.94 - $65.35 $198,341 - $216,243
3,309 New
3,309 $205,000
Q2 2017

May 23, 2019

SELL
N/A
-3,309 Closed
0 $0
Q1 2017

May 23, 2019

BUY
N/A
3,309 New
3,309 $205,000
Q3 2016

May 28, 2019

SELL
N/A
-2,810 Closed
0 $0
Q2 2016

May 28, 2019

BUY
N/A
2,810
2,810 $207,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Zhang Financial LLC Portfolio

Follow Zhang Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zhang Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zhang Financial LLC with notifications on news.